Expression and Significance of LINC02418 in Breast Cancer

References

• Yuanliang Yan QL, Liu Y, Zhou S, Zhijie X. COL12A1 as a prognostic biomarker links immunotherapy response in breast cancer. Endocr Relat Cancer. 2023;30.
   PubMed Web of Science ®Google Scholar
• Soofiyani SR, Hosseini K, Ebrahimi T, et al. Prognostic value and biological role of mir-126 in breast cancer. MicroRNA. 2022;11(2):95–103. doi:10.2174/1876402914666220428123203
   PubMedGoogle Scholar
• Yang X, Tang T, Zhou T. Prognosis and clinicopathological characteristics of metaplastic breast cancer: a meta-analysis. Medicine. 2022;101(49):e32226. doi:10.1097/MD.0000000000032226
   PubMed Web of Science ®Google Scholar
• Miao H, Hartman M, Bhoo-Pathy N, et al. Predicting survival of de novo metastatic breast cancer in Asian women: systematic review and validation study. PLoS One. 2014;9(4):e93755. doi:10.1371/journal.pone.0093755
   PubMed Web of Science ®Google Scholar
• Chen H, Xie G, Luo Q, Yang Y, Hu S. Regulatory miRNAs, circRNAs and lncRNAs in cell cycle progression of breast cancer. Funct Integrat Genomics. 2023;23(3):233. doi:10.1007/s10142-023-01130-z
   PubMed Web of Science ®Google Scholar
• Yao ZT, Yang YM, Sun MM, et al. New insights into the interplay between long non-coding RNAs and RNA-binding proteins in cancer. Cancer Communications. 2022;42(2):117–140. doi:10.1002/cac2.12254
   Web of Science ®Google Scholar
• Tan YT, Lin JF, Li T, Li JJ, Xu RH, Ju HQ. LncRNA-mediated posttranslational modifications and reprogramming of energy metabolism in cancer. Cancer Communications. 2021;41(2):109–120. doi:10.1002/cac2.12108
   PubMed Web of Science ®Google Scholar
• Mas AM, Huarte M. Long noncoding RNA signatures as cancer biomarkers. J Clinic Oncology. 2023;41(16):3059–3062. doi:10.1200/JCO.23.00381
   PubMed Web of Science ®Google Scholar
• Kong X, Duan Y, Sang Y, et al. LncRNA-CDC6 promotes breast cancer progression and function as ceRNA to target CDC6 by sponging microRNA-215. J Cell Physiol. 2019;234(6):9105–9117. doi:10.1002/jcp.27587
   PubMed Web of Science ®Google Scholar
• Zhang M, Wang Y, Jiang L, et al. LncRNA CBR3-AS1 regulates of breast cancer drug sensitivity as a competing endogenous RNA through the JNK1/MEK4-mediated MAPK signal pathway. J Exp Clin Cancer Res. 2021;40(1). doi:10.1186/s13046-021-01844-7
   Web of Science ®Google Scholar
• Shen Y, Peng X, Shen C. Identification and validation of immune-related lncRNA prognostic signature for breast cancer. Genomics. 2020;112(3):2640–2646. doi:10.1016/j.ygeno.2020.02.015
   PubMed Web of Science ®Google Scholar
• Yao F, Huang X, Xie Z, et al. LINC02418 upregulates EPHA2 by competitively sponging miR-372-3p to promote 5-Fu/DDP chemoresistance in colorectal cancer. Carcinogenesis. 2022;43(9):895–907. doi:10.1093/carcin/bgac065
   PubMed Web of Science ®Google Scholar
• Ye Y, Li H, Bian J, Wang L, Wang Y, Huang H. Exploring prognosis-associated biomarkers of estrogen-independent uterine corpus endometrial carcinoma by bioinformatics analysis. Int J Gen Med. 2021;14:9067–9081. doi:10.2147/IJGM.S341345
   PubMed Web of Science ®Google Scholar
• Sun Z, Mai H, Xue C, et al. Hsa-LINC02418/mmu-4930573I07Rik regulated by METTL3 dictates anti-PD-L1 immunotherapeutic efficacy via enhancement of Trim21-mediated PD-L1 ubiquitination. J ImmunoTherapy Cancer. 2023;11(12):e007415. doi:10.1136/jitc-2023-007415
   PubMedGoogle Scholar
• Wang T, Zhai R, Lv X, Wang K, Xu J. LINC02418 promotes malignant behaviors in lung adenocarcinoma cells by sponging miR-4677-3p to upregulate KNL1 expression. BMC Pulm Med. 2020;20(1):217. doi:10.1186/s12890-020-01229-0
   PubMed Web of Science ®Google Scholar
• Tian J, Cui P, Li Y, et al. LINC02418 promotes colon cancer progression by suppressing apoptosis via interaction with miR-34b-5p/BCL2 axis. Cancer Cell Int. 2020;20:460. doi:10.1186/s12935-020-01530-2
   PubMed Web of Science ®Google Scholar
• Rebello Alves L N, Dummer Meira D, Poppe Merigueti L, et al. Biomarkers in breast cancer: an old story with a new end. Genes. 2023;14(7). doi:10.3390/genes14071364
   Web of Science ®Google Scholar
• Sung H, Ferlay J, Siegel RL, et al. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. Ca A Cancer J Clinici. 2021;71(3):209–249. doi:10.3322/caac.21660
   PubMed Web of Science ®Google Scholar
• Hosonaga M, Saya H, Arima Y. Molecular and cellular mechanisms underlying brain metastasis of breast cancer. Cancer Metastasis Rev. 2020;39(3):711–720. doi:10.1007/s10555-020-09881-y
   PubMed Web of Science ®Google Scholar
• Michaels E, Worthington RO, Rusiecki J. Breast cancer risk assessment, screening, and primary prevention. Med Clin North Am. 2023;107(2):271–284. doi:10.1016/j.mcna.2022.10.007
   PubMed Web of Science ®Google Scholar
• Alsaab HO. Pathological role of long non-coding (lnc) RNA in the regulation of Wnt/β-catenin signaling pathway during epithelial-mesenchymal transition (EMT). Pathol Res Pract. 2023;248.
   Web of Science ®Google Scholar
• Xiuguo Yu JZ, Yaguang H, He Y. Long non-coding RNA PVT1 functions as an oncogene in human colon cancer through miR-30d-5p/RUNX2 axis. J buon. 2018;23(1):48–54.
   PubMed Web of Science ®Google Scholar
• Li Y, Zeng Q, Qiu J, Pang T, Xian J, Zhang X. Long non-coding RNA UCA1 promotes breast cancer by upregulating PTP1B expression via inhibiting miR-206. Cancer Cell Int. 2019;19:275. doi:10.1186/s12935-019-0958-z
   PubMed Web of Science ®Google Scholar
• Jiang X, Zhou Y, Sun AJ, Xue JL. NEAT1 contributes to breast cancer progression through modulating miR-448 and ZEB1. J Cell Physiol. 2018;233(11):8558–8566. doi:10.1002/jcp.26470
   PubMed Web of Science ®Google Scholar
• Dong H, Hu J, Zou K, et al. Activation of LncRNA TINCR by H3K27 acetylation promotes trastuzumab resistance and epithelial-mesenchymal transition by targeting MicroRNA-125b in breast cancer. Mol Cancer. 2019;18(1):3. doi:10.1186/s12943-018-0931-9
   PubMed Web of Science ®Google Scholar
• Lv M, Mao Q, Li J, Qiao J, Chen X, Luo S. Knockdown of LINC00665 inhibits proliferation and invasion of breast cancer via competitive binding of miR-3619-5p and inhibition of catenin beta 1. Cell Mol Biol Lett. 2020;25:43. doi:10.1186/s11658-020-00235-8
   PubMed Web of Science ®Google Scholar
• Wu X, Kong C, Wu Y. Long intergenic non-protein coding RNA 1094 (LINC01094) promotes the progression of breast cancer (BC) by regulating the microRNA-340-5p (miR-340-5p)/E2F transcription factor 3 (E2F3) axis. Bioengineered. 2021;12(1):9046–9057. doi:10.1080/21655979.2021.1993715
   PubMed Web of Science ®Google Scholar
• HAN B. LncRNA LINC02418 regulates proliferation and apoptosis of non-small cell lung cancer cells by regulating miR-4677-3p/SEC61G. Eur Rev Med Pharmacol Sci. 2019;23.
   Google Scholar
• Qi BS L, Yang B, Yang B, Lu S. Su lu long noncoding-RNA component of mitochondrial RNA processing endoribonuclease promotes carcinogenesis in triple-negative breast cancer cells via the competing endogenous RNA mechanism. J Breast Cancer. 2021;24(5):428–442. doi:10.4048/jbc.2021.24.e42
   PubMed Web of Science ®Google Scholar
• Bai Y, Zhang G, Cheng R, Yang R, Chu H. CASC15 contributes to proliferation and invasion through regulating miR-766-5p/ KLK12 axis in lung cancer. Cell Cycle. 2019;18(18):2323–2331. doi:10.1080/15384101.2019.1646562
   PubMed Web of Science ®Google Scholar
• Huang C, Su X, Zhou D-L, et al. A diagnostic and predictive lncRNA lnc-MPEG1-1 promotes the proliferation and metastasis of papillary thyroid cancer cells by occupying miR-766-5p. Mol Ther Nucleic Acids. 2022;28:408–422. doi:10.1016/j.omtn.2022.03.023
   PubMedGoogle Scholar